The researchers’ goal was to provide an overview of endpoints and outcomes in the current acute migraine clinical trial literature to facilitate the development of novel treatments.
Atogepant is an investigational orally administered calcitonin gene-related peptide (CGRP) receptor antagonist.
Study authors described the characteristics of youth with post-traumatic headache and determined whether the PTH phenotype was associated with outcome.
For COVID-19 long-haulers, neurologic symptoms are common, with 81 percent experiencing brain fog and 85 percent with fatigue.
For patients with acute posttraumatic headache presenting to the emergency department, intravenous M+D is more efficacious than placebo.
Researchers compared the impact of dry oxygen, dry air, humidified oxygen, and humidified air on patients suffering from acute headache episodes.
The purpose of this study was to evaluate the subsequent health resource utilization (HRU) of patients with migraine who received opioid medications at ED visits.
Liquid solution celecoxib may offer headache relief and improvements in functional disability in patients with migraine.
Researchers set out to evaluate whether propranolol efficacy is greater in people with comorbid migraine compared with those without migraine.
Study researchers assessed the brain connectivity patterns in the interictal phase of migraine and its relationship to migraine severity.